-
Bare Escentuals 4Q Fiscal 2009 Results
02/25/2010 –
Bare Escentuals Inc. announced financial results for the fourth fiscal quarter (4Q) and fiscal year ended Jan. 3, 2010.
-
Nu Skin Quarterly Dividends Increase
02/23/2010 –
Nu Skin Enterprises Inc.’s board of directors declared a 9-percent increase in the quarterly cash dividend to $0.125 per share.
-
Allylix Secures $6M Venture Funding
02/10/2010 –
Allylix Inc. raised $6 million in the first closing of its Series C financing. The money will allow the company to commercialize its first products for the fragrance industry, and allow it to advance several additional products in its pipeline.
-
-
Nu Skin Posts Record Results
02/05/2010 –
Nu Skin revenues were up for the fourth quarter of 2009, and fiscal year revenue was also up slightly, despite currency fluctuations and non-operating expenses.
-
Dr. Bronner’s Organic Lawsuit
01/04/2010 –
The California courts granted the motions filed by the defendants to dismiss for lack of subject-matter and failure to state a claim in favor of the defendants in the Dr. Bronner lawsuit.
-
Ceapro Raises $500K in Private Placement
12/22/2009 –
Ceapro received TSX-V approval for a private placement of $500,000 in funds, with a second tranche of convertible debentures in pursuit.
-
Sanofi-aventis Acquiring Chattem
12/22/2009 –
The French pharmaceutical firm Sanofi-Aventis gains a foothold in the U.S. health care market with its acquisition of Chattem Inc., which may allow conversion of certain pregascription meds to OTC and expand the existing cosmeceutical offerings of Chattem.